Period 2 protein inhibits cardiomyocyte death induced by β1-adrenoceptor autoantibodies

Por LI Pengjia, JIA Weiwei, LU Jiebei, MA Mingxia, ZHOU Xiuya, WANG Ning
Publicado em 2022-05-01

Molecular mechanisms governing different pharmacokinetics of ginsenosides and potential for ginsenoside-perpetrated herb–drug interactions on OATP1B3

Por Jiang, Rongrong, Dong, Jiajia, Li, Xiuxue, Du, Feifei, Jia, Weiwei, Xu, Fang, Wang, Fengqing, Yang, Junling, Niu, Wei, Li, Chuan
Publicado no Br J Pharmacol (2015)

Glycyrrhizin has a high likelihood to be a victim of drug–drug interactions mediated by hepatic organic anion‐transporting polypeptide 1B1/1B3

Por Dong, Jiajia, Olaleye, Olajide E, Jiang, Rongrong, Li, Jing, Lu, Chuang, Du, Feifei, Xu, Fang, Yang, Junling, Wang, Fengqing, Jia, Weiwei, Li, Chuan
Publicado no Br J Pharmacol (2018)

Assay development for determination of DZ2002, a new reversible SAHH inhibitor, and its acid metabolite DZA in blood and application to rat pharmacokinetic study

Por Jia, Weiwei, Li, Jing, Du, Feifei, Sun, Yan, Xu, Fang, Wang, Fengqing, Olaleye, Olajide E., Chen, Danghui, Tang, Wei, Zuo, Jianping, Li, Chuan
Publicado no J Pharm Anal (2019)